2018
DOI: 10.1027/2151-2604/a000320
|View full text |Cite
|
Sign up to set email alerts
|

An Update of a Meta-Analysis on the Clinical Outcomes of Deep Transcranial Magnetic Stimulation (DTMS) in Major Depressive Disorder (MDD)

Abstract: Abstract. Deep transcranial magnetic stimulation (DTMS) is a noninvasive therapy for treatment-resistant major depressive disorder (MDD). The current study aimed to update a previous meta-analysis by investigating the acute and longer-term clinical outcomes of DTMS and their possible predictors (patient characteristics and stimulation parameters) in unipolar MDD. A systematic literature search identified 11 studies with 282 treatment-resistant, unipolar MDD patients. The clinical outcomes (depression severity,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
4
0

Year Published

2018
2018
2025
2025

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 46 publications
0
4
0
Order By: Relevance
“…Another promising method—known as deep TMS (dTMS)—is a noninvasive technique allowing for stimulation of deeper cortical areas and presumably deeper neural networks [ 38 , 39 ]. Since the approval of dTMS in 2013 by the US Food and Drug Administration for major depressive disorder [ 40 ], this method of intervention has gained popularity for the treatment of diverse psychiatric disorders.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Another promising method—known as deep TMS (dTMS)—is a noninvasive technique allowing for stimulation of deeper cortical areas and presumably deeper neural networks [ 38 , 39 ]. Since the approval of dTMS in 2013 by the US Food and Drug Administration for major depressive disorder [ 40 ], this method of intervention has gained popularity for the treatment of diverse psychiatric disorders.…”
Section: Introductionmentioning
confidence: 99%
“…Since the approval of dTMS in 2013 by the US Food and Drug Administration for major depressive disorder [40], this method of intervention has gained popularity for the treatment of diverse psychiatric disorders.…”
Section: Introductionmentioning
confidence: 99%
“…Whereas replications and extensions of previous meta-analyses were not represented in the first issue, two articles of the current issue fall in this category (i.e., Gellersen & Kedzior, 2018; Steiger & Kühberger, 2018). The contribution by Helena Gellersen and Karina Karolina Kedzior (2018) entitled “An update of a meta-analysis on the clinical outcomes of deep transcranial magnetic stimulation (DTMS) in major depressive disorder (MDD)” aims at replicating and extending previous meta-analytic findings on DTMS effectiveness in depression. Major depressive disorder is the most widespread mental illness and for a significant number of patients, antidepressant medication is ineffective.…”
mentioning
confidence: 97%
“…Concerning the third and fourth category of papers we invited, the present Hotspots issue is somewhat complementary to the first one. Whereas replications and extensions of previous meta-analyses were not represented in the first issue, two articles of the current issue fall in this category (i.e., Gellersen & Kedzior, 2018;Steiger & Kühberger, 2018). The contribution by Helena Gellersen and Karina Karolina Kedzior (2018) entitled "An update of a metaanalysis on the clinical outcomes of deep transcranial magnetic stimulation (DTMS) in major depressive disorder (MDD)" aims at replicating and extending previous metaanalytic findings on DTMS effectiveness in depression.…”
mentioning
confidence: 98%